Condition
Neoplasms, Connective Tissue
Total Trials
4
Recruiting
2
Active
2
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 80/100
Termination Rate
50.0%
2 terminated out of 4 trials
Success Rate
0.0%
-86.5% vs benchmark
Late-Stage Pipeline
50%
2 trials in Phase 3/4
Results Transparency
0%
2 of 0 completed with results
Key Signals
2 with results0
Data Visualizations
Phase Distribution
4Total
P 1 (1)
P 2 (1)
P 3 (1)
P 4 (1)
Trial Status
Terminated2
Recruiting2
Clinical Trials (4)
Showing 4 of 4 trials
NCT05160168Phase 1Terminated
A Study of THE-630 in Patients With Advanced Gastrointestinal Stromal Tumors (GIST)
NCT05057130Phase 2Recruiting
Neoadjuvant Combination of Doxorubicin, Cisplatin and Methotrexate in Patients Aged 24-40 Years With Primary Bone Tumors
NCT05440240Phase 4Recruiting
Percutaneous Needle Fasciotomy +/- Corticosteroid Injection for Dupuytren's Contracture
NCT03495921Phase 3Terminated
A Trial For Participants With Ewing's Sarcoma Treated With Vigil in Combination With Irinotecan and Temozolomide
Showing all 4 trials